36.76

2.83% -1.07

After Hours: 36.44 -0.32 -0.87%

Indivior Pharmaceuticals Inc (INDV)

Overview News Price History Discussions Forecast

Indivior Pharmaceuticals Inc stock is traded at $36.76, with a volume of 1.82M. It is down -2.83% in the last 24 hours and up +13.04% over the past month. Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).

Previous Close:

$37.83

Open:

$37.51

24h Volume:

1.82M

Relative Volume:

0.71

Market Cap:

$4.35B

Revenue:

$1.29B

Net Income/Loss:

$251.00M

P/E Ratio:

18.62

EPS:

1.9744

Net Cash Flow:

$-193.86M

1W Performance:

-6.94%

1M Performance:

+13.04%

6M Performance:

+20.56%

1Y Performance:

+232.07%

1-Day Range:

$36.62

$37.90

1-Week Range:

$36.62

$39.70

52-Week Range:

$11.04

$41.00

Indivior Pharmaceuticals Inc Stock (INDV) Company Profile

Name

Indivior Pharmaceuticals Inc

Sector

Healthcare (1101)

Industry

Drug Manufacturers - Specialty & Generic (84)

Phone

804-379-1090

Address

10710 MIDLOTHIAN TURNPIKE, NORTH CHESTERFIELD

Employee

838

Twitter

Next Earnings Date

2026-04-30

Latest SEC Filings

INDV's Discussions on Twitter

Compare INDV vs TAK, TEVA, HLN, ZTS, UTHR

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
INDV Indivior Pharmaceuticals Inc	36.76	4.47B	1.29B	251.00M	-193.86M	1.9744
TAK Takeda Pharmaceutical Co Adr	16.61	52.55B	29.91B	1.30B	3.49B	0.4056
TEVA Teva Pharmaceutical Industries Ltd Adr	34.29	41.12B	17.53B	1.58B	444.18M	1.3457
HLN Haleon Plc Adr	8.96	39.50B	14.54B	2.22B	2.58B	0.4871
ZTS Zoetis Inc	74.22	31.64B	9.51B	2.64B	2.14B	6.0361
UTHR United Therapeutics Corp	568.58	24.44B	3.17B	1.29B	1.01B	27.09

Indivior Pharmaceuticals Inc Stock (INDV) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Aug-06-25	Initiated	H.C. Wainwright	Buy
Jul-22-25	Resumed	Jefferies	Buy
Jan-28-25	Initiated	Rodman & Renshaw	Buy
Jul-23-24	Initiated	Piper Sandler	Overweight
Apr-03-24	Initiated	Craig Hallum	Buy
Jul-13-23	Initiated	Northland Capital	Outperform

View All

Indivior Pharmaceuticals Inc Stock (INDV) Latest News

05:27 AM

Indivior Eliminates Chief Scientific Officer Role, Realigns Leadership - TipRanks

05:27 AM

09:18 AM

Madison Avenue entities (INDV) disclose 4.32M-share, ~3.5% stake - Stock Titan

09:18 AM

May 14, 2026

Bears are losing control over Indivior Pharmaceuticals Inc. (INDV), here's why it's a 'buy' now - MSN

May 14, 2026

Bears are Losing Control Over Indivior Pharmaceuticals Inc. (INDV), Here's Why It's a 'Buy' Now - Yahoo Finance

May 14, 2026

Indivior’s CEO lines up June investor meetings in New York and Miami - Stock Titan

May 14, 2026

Naloxone Market to See Booming Growth 2026-2033 | EMERGENT, Indivior PLC, Akorn, Inc - openPR.com

May 14, 2026

Indivior launches $175M accelerated share buyback - MSN

May 14, 2026

May 13, 2026

Fuller & Thaler Asset Mgmt (NASDAQ: INDV) holds 4.53M shares, 3.72% - Stock Titan

May 13, 2026

May 12, 2026

Number of shareholders of Indivior Pharmaceuticals, Inc. – NASDAQ:INDV - TradingView

May 12, 2026

Why One Fund Made a $23 Million Bet on This Addiction-Treatment Stock Amid a Staggering Rally - AOL.com

May 12, 2026

May 11, 2026

Net income before discontinued operations of Indivior Pharmaceuticals, Inc. – TRADEGATE:E7P - TradingView

May 11, 2026

Equity in earnings of Indivior Pharmaceuticals, Inc. – TRADEGATE:E7P - TradingView

May 11, 2026

Working capital per share of Indivior Pharmaceuticals, Inc. – TRADEGATE:E7P - TradingView

May 11, 2026